Please login to the form below

Not currently logged in
Email:
Password:

pregabalin

This page shows the latest pregabalin news and features for those working in and with pharma, biotech and healthcare.

Vyndaqel a bright spot as Pfizer comes under pressure

Vyndaqel a bright spot as Pfizer comes under pressure

The top line was however dragged down by the onset of generic competition in the US to severe pain drug Lyrica (pregabalin), which plunged to $433m from $1.32bn a year

Latest news

More from news
Approximately 0 fully matching, plus 27 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...

Infographics